|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Moderna (NASDAQ: MRNA) through any online brokerage.
The latest price target for Moderna (NASDAQ: MRNA) was reported by UBS on January 21, 2022. The analyst firm set a price target for 221.00 expecting MRNA to rise to within 12 months (a possible 38.06% upside). 32 analyst firms have reported ratings in the last year.
The stock price for Moderna (NASDAQ: MRNA) is $160.07 last updated Fri Jan 21 2022 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Moderna.
Moderna’s $Q4 earnings are confirmed for after-market on February 24, 2022.
There is no upcoming split for Moderna.
Moderna is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.